Rosenstock predicts that orforglipron and other similar small-molecule pills will eventually form the backbone of mainstream diabetes treatment, a role played today by the older glucose-lowering drug metformin: I can see these molecules as a first-line therapy, he says, prescribed to patients from day one. New Treatment Targets Drug developers are also racing to devise medications that drive even greater weight loss and offer more comprehensive overall health benefits, primarily by testing new agents that affect more than just the GLP-1 hormone receptor
However, the recurrence and metastasis rates are high, especially in NF1-related cases
For daily medications, skip the missed dose if more than 12 hours have passed and continue with the next scheduled dose
Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome
2017 Jan 15;440:106-115 16.1 Duntas LH
Most studies of ipamorelin have been short-term